OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← ZEO management

Full background report

Peter Zardo

Managing Director

Career chronology

  • More than 17 years before April 2020: Westpac Group — Senior leadership, corporate and institutional banking; earlier financial/equity markets. Our People (Our People, Peter Zardo biography, lines 59–63)

  • 7 April 2020 to July 2020: Zeotech Limited — Chief Operating Officer. Annual Report 2025 (pp. 21–22, Peter Zardo service agreement; role commenced COO and amended to MD July 2020)

  • July 2020 to cutoff: Zeotech Limited — Managing Director. Annual Report 2025 (pp. 21–22, Peter Zardo service agreement)

Education and qualifications

Education and professional qualification

As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality

The issuer states that Zardo undertook Applied Science studies at Charles Sturt University and is an MAICD member. It does not identify a degree or graduation date; these claims are not independently verified.

Attribution: Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained.

Relevance: Relevant to role-fit assessment and subject to verification gap.

Our People (Our People, Peter Zardo biography, lines 61–63)

Contributions and company outcomes

FY2026 project and commercial milestones

FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality

During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate managing director's personal contribution or establish booked DSO/AusPozz sales.

Attribution: Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented.

Relevance: Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue.

Annual Report to shareholders (FY2026 annual report, Chair/MD reports and operating review); Quarterly Activities and Appendix 5B Cash Flow Report (pp. 1–8, activities report)

Business failures and setbacks

Pre-commercial status and funding dependence

FY2026 to 2026-06-30 · issuer reported · medium materiality

FY2026 reporting showed the Group remained pre-commercial, with a larger annual loss and operating cash outflow than the prior year; the annual report disclosed that additional funding may be needed to continue operations and develop assets. This is a company-level execution/funding risk during the executive's tenure, not evidence of personal misconduct or sole responsibility.

Attribution: Role overlaps event; causation unproven. The MD role overlapped the reported period; no personal causal attribution is established.

Relevance: Material to assessing delivery and capital allocation for a development-stage company.

Annual Report to shareholders (FY2026 annual report, financial statements and going-concern funding risk)

Litigation and enforcement

Unresolved exact-name court match: Fair Work Act penalty

2015 incident; judgment 2017-04-07 · documented · medium materiality

A 2017 Federal Circuit Court judgment names a Peter Zardo as the third respondent and found a contravention of Fair Work Act s.502(1): the court found deliberate and persistent obstruction of a permit holder seeking to consult a worker, and imposed a $1,000 penalty. The published judgment identifies project-management activity at a construction site but does not identify Zeotech, Westpac, or the executive biography; identity match to Zeotech’s MD is therefore unconfirmed and the finding is not attributed to him. The retrieved judgment contains no later appeal or correction reference; no appellate search located a later resolution.

Attribution: Responsibility unresolved. The court made a finding against the exact-name respondent, but source material does not establish that he is the Zeotech executive.

Relevance: Potentially relevant only if identity can be established; no executive misconduct conclusion is drawn from name alone.

Construction, Forestry, Mining and Energy Union v Class 1 Form Pty Ltd [2017] FCCA 696 (paras. 44–48, 55–73, 103–111 and 331–343)

Abercorn project milestone-rights litigation settled

2023; acquisition term sheet dated 2019-08-09 · issuer reported · medium materiality

Zeotech reported that court-ordered mediation over milestone performance rights issued as consideration for the 2019 Abercorn acquisition concluded in 2023, with a binding settlement/release and discontinuance of both proceedings conditional on shareholder approval. The disclosure does not describe any finding of wrongdoing by the named executive; the dispute originated in a pre-appointment transaction and settlement terms were company-level.

Attribution: Role overlaps event; causation unproven. The MD/CEO roles overlapped settlement execution/oversight; no personal involvement or wrongdoing is documented.

Relevance: Relevant as company legal/governance context; resolution status disclosed as settlement, not adjudication of merits.

Quarterly Activities Report (March 2023 quarter) (p. 8, Settlement of legal proceedings)

Suitability for the current role

Role relevance and evidenced background

Background reviewed through 2026-10-09 · analyst inference · low materiality

The issuer reports 17+ years with Westpac, joining Zeotech as COO in 2020 and becoming MD in July 2020; it describes finance and commercialisation experience. Current title in the selected roster: Managing Director. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes.

Attribution: Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made.

Relevance: Relevant to the current Managing Director responsibilities, subject to the evidence limitations recorded below.

Our People (Executive biography or corporate-directory entry for the named person)

Evidence gaps

  • The exact-name 2017 court respondent cannot be confirmed as the Zeotech executive from the judgment; no independent identifier or employer link was found.

  • Applied Science study is not reported as a completed degree; Westpac chronology and concurrent interests have not been independently verified.

  • No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.